Quarterly Consolidated Statement Of Cash Flows

Perseus Proteomics Inc. - Filing #7246059

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-719,517,000 JPY
-832,018,000 JPY
Income taxes paid
-1,927,000 JPY
-1,927,000 JPY
Net cash provided by (used in) operating activities
-719,485,000 JPY
-833,898,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-75,157,000 JPY
-142,998,000 JPY
Net cash provided by (used in) investing activities
-75,157,000 JPY
-150,343,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-1,000 JPY
Net cash provided by (used in) financing activities
923,381,000 JPY
63,943,000 JPY
Effect of exchange rate change on cash and cash equivalents
-2,237,000 JPY
16,783,000 JPY
Net increase (decrease) in cash and cash equivalents
126,501,000 JPY
-903,514,000 JPY
Cash and cash equivalents
1,667,921,000 JPY
1,541,419,000 JPY
2,444,934,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.